Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers
NCT06910579Phase 3Recruiting
- Sponsor
- The British University in Egypt
- Start
- Mar 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Recurrent aphthous stomatitis (RAS) (2 arms), sponsored by The British University in Egypt. Primary endpoint: Pain intensity at 10 days. Started Mar 2025; status: recruiting.
02
Conditions
Recurrent aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT06910579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06910579.